JIN Yang Pharmaceutical

진양제약 · 007370

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$41.8M (₩57.7B)

Overview

JIN Yang Pharmaceutical makes medicines, including both prescription drugs and over-the-counter products, used by patients and dispensed through hospitals, clinics, and pharmacies in South Korea.

The company also engages in importing and exporting pharmaceuticals. It is listed on KOSDAQ, South Korea's tech and small-cap exchange. Its product portfolio centres on generic medicines, drugs whose original patents have expired, which is the dominant model across the domestic Korean pharmaceutical industry.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$87.5M

▲ +6.5% YoY

Operating profit · FY2025

US$1.8M

▼ −78.4% YoY

Net income · FY2025

US$16.1M

▼ −24.9% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$68.2M(₩94.1B)	US$82.1M(₩113.3B)	US$87.5M(₩120.7B)
Operating profit	US$6.6M(₩9.1B)	US$8.5M(₩11.7B)	US$1.8M(₩2.5B)
Net income	US$9.2M(₩12.7B)	US$21.5M(₩29.7B)	US$16.1M(₩22.3B)

Revenue

FY2023US$68.2M
FY2024US$82.1M
FY2025US$87.5M

Operating profit

FY2023US$6.6M
FY2024US$8.5M
FY2025US$1.8M

Net income

FY2023US$9.2M
FY2024US$21.5M
FY2025US$16.1M

Key ratios (FY2025)

ROE

13.9%

Debt/Eq

67.5%

Op. margin

2.1%

Net margin

18.5%

Rev. YoY

▲ +6.5%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?